RNA Formulation Solutions
-
Mobius® Power MIX Single-Use Mixing Systems
8/4/2021
The Mobius® Power MIX single-use mixing systems combine high performance mixing technology with design features that make them easy-to-use. The impeller design and motor are based on our magnetically coupled NovAseptic® mixing technology, a proven mixing technology in stainless steel tanks. These systems efficiently mix the most challenging buffers, media and biopharmaceutical ingredients.
-
GenVoy-ILM™ T-Cell Kits For mRNA
4/24/2025
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
-
Customized Skid For Large Production Scale: IJM NanoProducer
12/9/2024
The Impingement Jets Mixing (IJM) Large Production Scale Units are designed for high-flow production of nanoparticles (LNP, micro-emulsions, etc) and can be configured with up to eight parallel mixing units depending on customer requirements.
-
GenVoy-ILM™ T Cell Kit For mRNA, Ignite™
7/1/2022
GenVoy-ILM™ T Cell Kit for mRNA, Ignite is an lipid nanoparticle (LNP) reagent mix optimized for the delivery of messenger RNA (mRNA) or Cas9 mRNA/sgRNA into activated human primary T cells.
-
mRNA/LNP Development And Manufacturing Services
Messenger RNAs (mRNAs) represent a fast-emerging class of biotherapeutics. In recent years, we at Lonza have amassed considerable expertise in the commercial manufacturing of mRNA and its encapsulation in Lipid Nanoparticles (LNP) at cGMP quality.
-
GenVoy-ILM™: Power To Explore
4/14/2022
GenVoy-ILM is a pre-optimized lipid mixture designed to encapsulate RNA – mRNA, gRNA, siRNA, miRNA, tRNA – in LNP.
-
Accelerate Development With Large-Scale mRNA And LNP Production
10/16/2024
Achieve scalable purity with Vernal Biosciences' mRNA and lipid nanoparticle (LNP) large-scale production, tailored to meet the demands of your preclinical studies, including dose range finding and toxicology assessments.
-
NanoAssemblr® Spark™: Freedom To Discover
4/14/2022
The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.
-
Non-Viral In Vivo Transfection - Cationic Lipids For LNP Formulation
7/13/2023
LipidBrick® IM21.7c
- Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
- Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
- Accelerate your project: in vitro and in vivo proof of concept have been successfully performed
-
Plasmid DNA Manufacturing
1/31/2023
As a critical starting material in the production of many advanced therapies including viral vectors and RNA vaccines, cell and gene therapy research at any scale requires plasmid DNA manufacturing. Our specialists provide custom plasmid production that fits your project specifications. To save time and accelerate your cell and gene therapy programs, we also offer off-the-shelf, premanufactured, High Quality viral vector packaging plasmids.